Ingredion Incorporated

INGRNYSECIK 1046257Consumer Defensive / Packaged Foods & Farm Productsfiscal year ends December70 quarters since 2009

Revenue, Q3 FY2026
$1.8B
−1.3% on Q3 FY2025
Net income
$142M
−17.0% on Q3 FY2025
Free cash flow
$163M
−4.7% on Q3 FY2025
Diluted EPS
$2.23
−14.6% on Q3 FY2025
Revenue, TTM
$7.2B
trailing four quarters
Net margin, TTM
7.8%
net income $563M
Free cash flow, TTM
$347M
$794M less $447M capex
Cash and equivalents
$989M
long-term debt $1.2B, Sep 30, 2026
Shares, 12-month change
−2.0%
62M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$212M
3.6% of market value
Market value
$5.9B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Ingredion Incorporated reported revenue of $1.8B, −1.3% on Q3 FY2025, and net income of $142M (−17.0%). Operating margin was 11.2%. Free cash flow, operating cash flow less capital expenditures, was $163M ($266M less $103M). Diluted earnings per share were $2.23.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

INGR daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $93.33 · H $94.22 · L $93.06 · C $94.14 · +1.53% on the dayOver the range: −12.59%, Nov 14, 2025 to Nov 13, 2026
$88$97$107$116$125Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 6, 2026.

Revenue and net incomeRevenueNet income
$0$1B$2B$3BQ4'22, Revenue: $2.0BQ4'22, Net income: $114MQ4'22Q1'23, Revenue: $2.1BQ1'23, Net income: $191MQ1'23Q2'23, Revenue: $2.1BQ2'23, Net income: $163MQ2'23Q3'23, Revenue: $2.0BQ3'23, Net income: $158MQ3'23Q4'23, Revenue: $1.9BQ4'23, Net income: $131MQ4'23Q1'24, Revenue: $1.9BQ1'24, Net income: $216MQ1'24Q2'24, Revenue: $1.9BQ2'24, Net income: $148MQ2'24Q3'24, Revenue: $1.9BQ3'24, Net income: $188MQ3'24Q4'24, Revenue: $1.8BQ4'24, Net income: $95MQ4'24Q1'25, Revenue: $1.8BQ1'25, Net income: $197MQ1'25Q2'25, Revenue: $1.8BQ2'25, Net income: $196MQ2'25Q3'25, Revenue: $1.8BQ3'25, Net income: $171MQ3'25Q4'25, Revenue: $1.8BQ4'25, Net income: $165MQ4'25Q1'26, Revenue: $1.8BQ1'26, Net income: $142MQ1'26Q2'26, Revenue: $1.9BQ2'26, Net income: $114MQ2'26Q3'26, Revenue: $1.8BQ3'26, Net income: $142MQ3'26$0$1B$2B$3BQ4'22, Revenue: $2.0BQ4'22, Net income: $114MQ4'22Q1'23, Revenue: $2.1BQ1'23, Net income: $191MQ1'23Q2'23, Revenue: $2.1BQ2'23, Net income: $163MQ2'23Q3'23, Revenue: $2.0BQ3'23, Net income: $158MQ3'23Q4'23, Revenue: $1.9BQ4'23, Net income: $131MQ4'23Q1'24, Revenue: $1.9BQ1'24, Net income: $216MQ1'24Q2'24, Revenue: $1.9BQ2'24, Net income: $148MQ2'24Q3'24, Revenue: $1.9BQ3'24, Net income: $188MQ3'24Q4'24, Revenue: $1.8BQ4'24, Net income: $95MQ4'24Q1'25, Revenue: $1.8BQ1'25, Net income: $197MQ1'25Q2'25, Revenue: $1.8BQ2'25, Net income: $196MQ2'25Q3'25, Revenue: $1.8BQ3'25, Net income: $171MQ3'25Q4'25, Revenue: $1.8BQ4'25, Net income: $165MQ4'25Q1'26, Revenue: $1.8BQ1'26, Net income: $142MQ1'26Q2'26, Revenue: $1.9BQ2'26, Net income: $114MQ2'26Q3'26, Revenue: $1.8BQ3'26, Net income: $142MQ3'26$0$1B$2B$3BQ4'22, Revenue: $2.0BQ4'22, Net income: $114MQ1'23, Revenue: $2.1BQ1'23, Net income: $191MQ1'23Q2'23, Revenue: $2.1BQ2'23, Net income: $163MQ3'23, Revenue: $2.0BQ3'23, Net income: $158MQ3'23Q4'23, Revenue: $1.9BQ4'23, Net income: $131MQ1'24, Revenue: $1.9BQ1'24, Net income: $216MQ1'24Q2'24, Revenue: $1.9BQ2'24, Net income: $148MQ3'24, Revenue: $1.9BQ3'24, Net income: $188MQ3'24Q4'24, Revenue: $1.8BQ4'24, Net income: $95MQ1'25, Revenue: $1.8BQ1'25, Net income: $197MQ1'25Q2'25, Revenue: $1.8BQ2'25, Net income: $196MQ3'25, Revenue: $1.8BQ3'25, Net income: $171MQ3'25Q4'25, Revenue: $1.8BQ4'25, Net income: $165MQ1'26, Revenue: $1.8BQ1'26, Net income: $142MQ1'26Q2'26, Revenue: $1.9BQ2'26, Net income: $114MQ3'26, Revenue: $1.8BQ3'26, Net income: $142MQ3'26

Net income losses drawn in red.

Free cash flow
−$200M$0$200M$400M$600MQ4'22, Free cash flow: −$25MQ4'22Q1'23, Free cash flow: −$127MQ1'23Q2'23, Free cash flow: $252MQ2'23Q3'23, Free cash flow: $289MQ3'23Q4'23, Free cash flow: $327MQ4'23Q1'24, Free cash flow: $144MQ1'24Q2'24, Free cash flow: $257MQ2'24Q3'24, Free cash flow: $429MQ3'24Q4'24, Free cash flow: $311MQ4'24Q1'25, Free cash flow: −$15MQ1'25Q2'25, Free cash flow: $84MQ2'25Q3'25, Free cash flow: $171MQ3'25Q4'25, Free cash flow: $271MQ4'25Q1'26, Free cash flow: −$77MQ1'26Q2'26, Free cash flow: −$10MQ2'26Q3'26, Free cash flow: $163MQ3'26−$200M$0$200M$400M$600MQ4'22, Free cash flow: −$25MQ4'22Q1'23, Free cash flow: −$127MQ1'23Q2'23, Free cash flow: $252MQ2'23Q3'23, Free cash flow: $289MQ3'23Q4'23, Free cash flow: $327MQ4'23Q1'24, Free cash flow: $144MQ1'24Q2'24, Free cash flow: $257MQ2'24Q3'24, Free cash flow: $429MQ3'24Q4'24, Free cash flow: $311MQ4'24Q1'25, Free cash flow: −$15MQ1'25Q2'25, Free cash flow: $84MQ2'25Q3'25, Free cash flow: $171MQ3'25Q4'25, Free cash flow: $271MQ4'25Q1'26, Free cash flow: −$77MQ1'26Q2'26, Free cash flow: −$10MQ2'26Q3'26, Free cash flow: $163MQ3'26−$200M$0$200M$400M$600MQ4'22, Free cash flow: −$25MQ1'23, Free cash flow: −$127MQ1'23Q2'23, Free cash flow: $252MQ3'23, Free cash flow: $289MQ3'23Q4'23, Free cash flow: $327MQ1'24, Free cash flow: $144MQ1'24Q2'24, Free cash flow: $257MQ3'24, Free cash flow: $429MQ3'24Q4'24, Free cash flow: $311MQ1'25, Free cash flow: −$15MQ1'25Q2'25, Free cash flow: $84MQ3'25, Free cash flow: $171MQ3'25Q4'25, Free cash flow: $271MQ1'26, Free cash flow: −$77MQ1'26Q2'26, Free cash flow: −$10MQ3'26, Free cash flow: $163MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5B$2.0BQ4'22, Cash and equivalents: $236MQ4'22, Long-term debt: $1.9BQ4'22Q1'23, Cash and equivalents: $216MQ1'23, Long-term debt: $1.9BQ1'23Q2'23, Cash and equivalents: $257MQ2'23, Long-term debt: $1.9BQ2'23Q3'23, Cash and equivalents: $335MQ3'23, Long-term debt: $1.9BQ3'23Q4'23, Cash and equivalents: $401MQ4'23, Long-term debt: $1.7BQ4'23Q1'24, Cash and equivalents: $438MQ1'24, Long-term debt: $1.7BQ1'24Q2'24, Cash and equivalents: $505MQ2'24, Long-term debt: $1.7BQ2'24Q3'24, Cash and equivalents: $877MQ3'24, Long-term debt: $1.7BQ3'24Q4'24, Cash and equivalents: $997MQ4'24, Long-term debt: $1.8BQ4'24Q1'25, Cash and equivalents: $837MQ1'25, Long-term debt: $1.7BQ1'25Q2'25, Cash and equivalents: $861MQ2'25, Long-term debt: $1.7BQ2'25Q3'25, Cash and equivalents: $915MQ3'25, Long-term debt: $1.7BQ3'25Q4'25, Cash and equivalents: $1.0BQ4'25, Long-term debt: $1.7BQ4'25Q1'26, Cash and equivalents: $914MQ1'26, Long-term debt: $1.7BQ1'26Q2'26, Cash and equivalents: $948MQ2'26, Long-term debt: $1.7BQ2'26Q3'26, Cash and equivalents: $989MQ3'26, Long-term debt: $1.2BQ3'26$0$500M$1.0B$1.5B$2.0BQ4'22, Cash and equivalents: $236MQ4'22, Long-term debt: $1.9BQ4'22Q1'23, Cash and equivalents: $216MQ1'23, Long-term debt: $1.9BQ1'23Q2'23, Cash and equivalents: $257MQ2'23, Long-term debt: $1.9BQ2'23Q3'23, Cash and equivalents: $335MQ3'23, Long-term debt: $1.9BQ3'23Q4'23, Cash and equivalents: $401MQ4'23, Long-term debt: $1.7BQ4'23Q1'24, Cash and equivalents: $438MQ1'24, Long-term debt: $1.7BQ1'24Q2'24, Cash and equivalents: $505MQ2'24, Long-term debt: $1.7BQ2'24Q3'24, Cash and equivalents: $877MQ3'24, Long-term debt: $1.7BQ3'24Q4'24, Cash and equivalents: $997MQ4'24, Long-term debt: $1.8BQ4'24Q1'25, Cash and equivalents: $837MQ1'25, Long-term debt: $1.7BQ1'25Q2'25, Cash and equivalents: $861MQ2'25, Long-term debt: $1.7BQ2'25Q3'25, Cash and equivalents: $915MQ3'25, Long-term debt: $1.7BQ3'25Q4'25, Cash and equivalents: $1.0BQ4'25, Long-term debt: $1.7BQ4'25Q1'26, Cash and equivalents: $914MQ1'26, Long-term debt: $1.7BQ1'26Q2'26, Cash and equivalents: $948MQ2'26, Long-term debt: $1.7BQ2'26Q3'26, Cash and equivalents: $989MQ3'26, Long-term debt: $1.2BQ3'26$0$500M$1.0B$1.5B$2.0BQ4'22, Cash and equivalents: $236MQ4'22, Long-term debt: $1.9BQ1'23, Cash and equivalents: $216MQ1'23, Long-term debt: $1.9BQ1'23Q2'23, Cash and equivalents: $257MQ2'23, Long-term debt: $1.9BQ3'23, Cash and equivalents: $335MQ3'23, Long-term debt: $1.9BQ3'23Q4'23, Cash and equivalents: $401MQ4'23, Long-term debt: $1.7BQ1'24, Cash and equivalents: $438MQ1'24, Long-term debt: $1.7BQ1'24Q2'24, Cash and equivalents: $505MQ2'24, Long-term debt: $1.7BQ3'24, Cash and equivalents: $877MQ3'24, Long-term debt: $1.7BQ3'24Q4'24, Cash and equivalents: $997MQ4'24, Long-term debt: $1.8BQ1'25, Cash and equivalents: $837MQ1'25, Long-term debt: $1.7BQ1'25Q2'25, Cash and equivalents: $861MQ2'25, Long-term debt: $1.7BQ3'25, Cash and equivalents: $915MQ3'25, Long-term debt: $1.7BQ3'25Q4'25, Cash and equivalents: $1.0BQ4'25, Long-term debt: $1.7BQ1'26, Cash and equivalents: $914MQ1'26, Long-term debt: $1.7BQ1'26Q2'26, Cash and equivalents: $948MQ2'26, Long-term debt: $1.7BQ3'26, Cash and equivalents: $989MQ3'26, Long-term debt: $1.2BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Ingredion Incorporated income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue1,7921,8501,7921,7571,8161,8331,8131,800−1.3%
Cost of revenue1,3931,4241,3911,3271,3611,3561,3471,351+2.4%
Gross profit399426401430455477466449−12.3%
Research and development—————————
Selling, general and administrative—————————
Operating income201188203220249271276162−19.3%
Other income (expense)(2)(2)—(4)(1)00(1)−100.0%
Pretax income194175194207241259267152−19.5%
Income tax5259504069616855−24.6%
Net income14211414216517119619795−17.0%
Diluted EPS ($)2.231.782.222.562.612.993.001.43−14.6%
Diluted shares (millions)646464—656666——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Ingredion Incorporated balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents9899489141,030915861837997+8.1%
Short-term investments—————————
Total current assets3,5603,5233,5253,5053,5163,5173,3653,355+1.3%
Total assets8,1278,0707,9287,8977,8337,7817,4687,444+3.8%
Total current liabilities1,7741,2591,2771,3161,2781,2641,1821,281+38.8%
Long-term debt1,2421,7421,7421,7421,7411,7411,7421,787−28.7%
Total debt1,7751,7831,8251,7901,7981,7871,7841,831−1.3%
Total liabilities3,5183,4973,4823,5313,5093,5053,4203,554+0.3%
Stockholders’ equity4,5534,5244,3834,2744,2384,1973,9773,804+7.4%
Shares outstanding (millions)6263636364646464—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Ingredion Incorporated cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow266903340527718577436−4.0%
Capital expenditures10310011013410610192125−2.8%
Free cash flow (CFO − capex)163(10)(77)27117184(15)311−4.7%
Depreciation and amortization5555555757535554−3.5%
Share repurchases—————————
Dividends paid5353525451545254+3.9%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 17, 2026.

Income statement

Ingredion Incorporated income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 20, 2025FY2023ended Dec 31, 2023filed Feb 21, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 19, 2020FY2018ended Dec 31, 2018filed Feb 25, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 22, 2017FY2015ended Dec 31, 2015filed Feb 19, 2016FY2014ended Dec 31, 2014filed Feb 20, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Revenue7,2197,4308,1607,9466,8945,9876,2096,2896,2445,704———6,5326,2194,3673,6723,944
Cost of revenue5,3915,6396,4116,4525,5634,7154,8974,9214,7724,303————————
Gross profit1,8281,7911,7491,4941,3311,2721,3121,3681,4721,4011,2421,1151,1311,2381,126724520705
Research and development71676352434344———————————
Selling, general and administrative—————————579555525534556543370247275
Operating income1,016883957762310582664703836806660581613668671339153434
Other income (expense)(5)(3)(4)5125(1)46—————————
Pretax income974931839668248506582621769742599520547601593275115—
Income tax2382771881661231521581672372461871571441671709968130
Net income729647643492117348413443519485402355396428—16941267
Diluted EPS ($)11.189.719.607.341.735.156.136.177.066.555.514.745.055.475.322.200.543.52
Diluted shares (millions)656767676868677274747375787878777676

Balance sheet

Ingredion Incorporated balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 20, 2025FY2023ended Dec 31, 2023filed Feb 21, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 19, 2020FY2018ended Dec 31, 2018filed Feb 25, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 22, 2017FY2015ended Dec 31, 2015filed Feb 19, 2016FY2014ended Dec 31, 2014filed Feb 20, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Cash and equivalents1,030997401236328665264327595512434580574609401302175107
Short-term investments——————————————————
Total current assets3,5053,3553,3993,3092,6972,6472,1602,1382,4152,2521,9502,1442,2142,3602,1021,7541,045—
Total assets7,8977,4447,6427,5616,9996,8586,0405,7286,0805,7825,0745,0855,3535,5925,3175,0402,952—
Total current liabilities1,3161,2811,7721,8821,5121,458967946957978742721820933926873565—
Long-term debt1,7421,7871,7401,9401,7381,7481,7661,9311,7441,8501,8191,7981,7171,7241,8011,681408—
Total debt1,7901,8312,1882,4832,0462,1861,8482,1001,8641,9561,8381,8301,8101,8001,9491,769544—
Total liabilities3,5313,5543,9924,2993,7743,7863,268———————————
Stockholders’ equity4,2743,8043,5383,1473,1002,9512,7202,3882,8912,5652,1442,1772,4042,4372,1041,9751,681—
Shares outstanding (millions)63646666676767677272727274777676——

Cash flow statement

Ingredion Incorporated cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 20, 2025FY2023ended Dec 31, 2023filed Feb 21, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 19, 2020FY2018ended Dec 31, 2018filed Feb 25, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 22, 2017FY2015ended Dec 31, 2015filed Feb 19, 2016FY2014ended Dec 31, 2014filed Feb 20, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Operating cash flow9441,4361,057152392829680703769771686————394586(79)
Capital expenditures433295314300300340328350314284280276298313263159146228
Free cash flow (CFO − capex)5111,141743(148)92489352353455487406————235440(307)
Depreciation and amortization222214219215220213220247209196194195194211211155130128
Share repurchases————————1238413042281848531
Dividends paid2112101941811841781741821651411261281126950454542

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$6M
9 sales by 5 insiders; officers and directors $6M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 15, 2026Reynoso DiegoEVP & Chief Financial Officeraward5,396$97.27$525K5,396Oct 19, 2026
Oct 15, 2026Reynoso DiegoEVP & Chief Financial Officeraward7,264$97.27$707K12,660Oct 19, 2026
Aug 5, 2026Fischer David BDirectoropen-market sale1,662$102.31$170K19,930Aug 6, 2026
Jul 1, 2026Escoe T. KennethDirectoraward1,516$98.97$150K1,516Jul 2, 2026
May 20, 2026Wilson Dwayne AndreeDirectoraward1,797$107.34$193K30,536May 22, 2026
May 20, 2026Verduin PatriciaDirectoraward1,797$107.34$193K5,620May 22, 2026
May 20, 2026Uribe Jorge A.Directoraward1,797$107.34$193K14,815May 22, 2026
May 20, 2026Tanda Stephan B.Directoraward1,797$107.34$193K1,797May 22, 2026
May 20, 2026Talbot SiobhanDirectoraward1,797$107.34$193K1,797May 22, 2026
May 20, 2026Suever Catherine ADirectoraward1,797$107.34$193K8,710May 22, 2026
May 20, 2026Reich VictoriaDirectoraward1,797$107.34$193K21,927May 22, 2026
May 20, 2026Magro Charles V.Directoraward1,797$107.34$193K11,345May 22, 2026
May 20, 2026Jordan Rhonda LDirectoraward1,797$107.34$193K28,909May 22, 2026
May 20, 2026Fischer David BDirectoraward1,797$107.34$193K21,435May 22, 2026
May 2, 2026Ritchie Robert A.EVP, Food & Industrial Ingred.tax withholding842$110.43$93K31,178May 5, 2026
Apr 16, 2026Tanda Stephan B.Directorgift380$0.00—0Apr 16, 2026
Apr 16, 2026Tanda Stephan B.Directorgiftindirect380$0.00—10,737Apr 16, 2026
Apr 15, 2026Uribe Jorge A.Directorgift312$0.00—12,925Apr 16, 2026
Apr 15, 2026Uribe Jorge A.Directorgiftindirect312$0.00—6,449Apr 16, 2026
Apr 9, 2026Tanda Stephan B.Directorgift1,557$0.00—380Apr 13, 2026
Apr 9, 2026Tanda Stephan B.Directorgiftindirect1,557$0.00—10,357Apr 13, 2026
Mar 31, 2026Wilson Dwayne AndreeDirectoraward380$112.66$43K28,535Apr 2, 2026
Mar 31, 2026Verduin PatriciaDirectoraward380$112.66$43K3,823Apr 2, 2026
Mar 31, 2026Uribe Jorge A.Directoraward380$112.66$43K13,305Apr 2, 2026
Mar 31, 2026Uribe Jorge A.Directortax withholding67$112.66$8K13,238Apr 2, 2026

Full insider history for Ingredion Incorporated, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held INGR in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded INGR by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$20M204,1000.03%added +45.7%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
INGREDION INCORPORATED, CIK 1046257 on EDGAR
Extract generated
November 16, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: revenue FY2017
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2024
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss, NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total debt: LongTermDebt, LongTermDebt+short-term, combined, noncurrent+DebtCurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/INGR.json